Clinical Trial

Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients

Recruiting
View on ClinicalTrials.gov →
Summary
DFNA9 (Deafness Autosomal Dominant 9) is an autosomal dominant hereditary hearing loss which is associated with vestibular deterioration. The most recent genotype-phenotype correlation studies have been conducted more than 15 years ago. Meanwhile, emerging and valuable vestibular tests have been added to the vestibular test battery. These tests were not available at the time of the correlation studies. The aim of this study is to carry out a prospective cross-sectional study on symptomatic and presymptomatic affected carriers of the Pro51Ser (P51S) Coagulation Factor C Homology (COCH) mutation in order to correlate vestibular data using the complete vestibular test battery with the known data on hearing and vestibular function in relation to age.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2018-10-22; most recent amendment 2021-10-27.
Trial Details
NCT Number NCT03716908
Lead Sponsor Jessa Hospital
Collaborators: University Hospital, Antwerp, Maastricht University Medical Center
Conditions Vestibular Diseases, DFNA9
Enrollment 70 participants
Start Date 2018-06-01
Primary Completion 2020-02-15 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2021-10-28